BioCurity has developed drugs to protect cancer patients from the side effects of radiation therapy. They have issued US patents and have a growing IP portfolio. The management team is focused on meeting development milestones to increase the company's valuation.
Organizations Involved
MD Anderson Cancer Center, State University
Founders
Dr. Cheryl Baker, Sam Merchant, Nancy Cass
Company Description
BioCurity is a biopharmaceutical company developing drugs to transform radiation therapy. Their mission is to prevent certain side effects of radiation therapy for cancer patients. The proposed drugs under development are from BioCurity’s patented technology and have been preclinically tested for multiple cancers including breast, lung, head and neck, prostate, and colorectal cancer.